Used as main image by Phynd in search results and profile page

Stephanie Bochen Tsai, MD

Hematology, Hematology & Oncology, Internal Medicine, Medical Oncology

Provider Groups

  • Loyola Medicine Physician

  • Loyola Physician Partners

Primary Contact

(888)584-7888
Provider Groups
  • Loyola Medicine Physician

  • Loyola Physician Partners

Primary Contact
(888)584-7888

Services & Specialties

Areas of Specialization

  • Hematology
  • Hematology & Oncology
  • Internal Medicine
  • Medical Oncology

Clinical Interests

Conditions Treated

  • leukemia
  • non hodgkin lymphoma
  • thrombocytopenia
  • acute lymphoblastic leukemia (all)
  • acute myelogenous leukemia (aml)
  • bone marrow disorders
  • chronic lymphocytic leukemia
  • multiple myeloma
  • myelodysplastic syndrome

Locations & Contact

Primary Location

Loyola University Medical Center

2160 S First Ave
Maywood , IL 60153

View hours
Tuesday
8:00am - 5:00pm
Monday
8:00am - 5:00pm
Wednesday
8:00am - 5:00pm
Thursday
8:00am - 5:00pm
Friday
8:00am - 5:00pm
Saturday
8:00am - 5:00pm
Sunday
8:00am - 5:00pm
Loyola University Medical Center

Michiana Hematology Oncology PC

5340 Holy Cross Pkwy
Mishawaka , IN 46545

About

Treating hematology disorders, with a focus on leukemias and hematopoietic stem cell transplantation (HCY), including all phases of treatment. Emphasizes provision of comprehensive and compassionate care to patients and their support, while applying the latest advances, therapies, and available knowledge. Research efforts concentrate on leukemias, as a member of national working groups and leader for the Loyola Leukemia Research program, as well as in HCT.

Academic Title

Associate Professor

Leadership Title

Unit Medical Director, Division of Hematology/Oncology
Leader, Loyola Leukemia Research Program
Quality Medical Director, Hematology/Oncology/BMT

Ages Seen

Adults - Over 65
Adults - 18 to 64

Procedures Performed

  • cancer

Additional Resources

Education & Certifications

Education

Education:
Boston University School of Medicine (2009)

Residency:
Boston Medical Center (2012)

Fellowship:
The University of Chicago Hospitals and Health System (2015)

Board Certifications

Hematology, Hematology, American Board of Internal Medicine Subspecialty (2017)

Medical Oncology, Medical Oncology, American Board of Internal Medicine Subspecialty (2015)

Internal Medicine, Internal Medicine, American Board of (2012)

Provider Groups

Loyola Medicine Physician

Loyola Physician Partners

Provider Ratings

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn More >

4.8 out of 5

(74 ratings)

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

21 Reviews

07/23/2024

Dr Tsia allways makes me feel comfortable and easy to talk with. I noticed that she would stop typing to give me her full attention when i have a concern.

07/15/2024

Future medical director:)

06/20/2024

Caring and treating well

06/18/2024

They were very very good and listened

06/13/2024

She’s the BEST!

06/10/2024

Compassionate, funny knowledgeable

05/14/2024

Always positive.

04/04/2024

I appreciate the full attention they give when i bring up a cooncern

01/04/2024

SHe was OK

12/26/2023

I have been seeing her for a long time and everything is always very good.

11/28/2023

Prompt, courteous service

11/23/2023

My doctors are great

10/05/2023

I feel like my provider is concerned about my well being

10/05/2023

Both Md and ApN experience very good

09/21/2023

I trust this provider

08/30/2023

top notch as always

08/05/2023

Be on time would be helpful .

08/03/2023

Loyola has been great to me and great doctors

07/27/2023

Almost thought we were forgotten while waiting for the doctor.

07/23/2023

Dr Tsai is a good listener and she always has an answer to my questions. She’s feel like she empowers me with my icondition. She is the reason I decided to get off my meds because she had a lot of evidence based research.

07/08/2023

Simply the best
Show more

Publications

  • Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL. Roloff, G. W.; Aldoss, I.; Kopmar, N. E.; Lin, C.; Dekker, S. E.; Gupta, V. K.; O'Connor, T. E.; Jeyakumar, N.; Muhsen, I. N.; Valtis, Y.; Ahmed, N.; Zhang, A.; Miller, K.; Dykes, K. C.; Ahmed, M.; Chen, E. C.; Mercadal, S.; Schwartz, M.; Tracy, S. I.; Dholaria, B.; Mukherjee, A.; Battiwalla, M.; Logan, A. C.; Ladha, A.; Guzowski, C.; Hoeg, R. T.; Hilal, T.; Moore, J.; Connor, M. P.; Hill, L. C.; Tsai, S. B.; Sasine, J. P.; Solh, M. M.; Kota, V. K.; Koura, D.; Veeraputhiran, M.; Leonard, J. T.; Frey, N. V.; Park, J. H.; Luskin, M. R.; Bachanova, V.; Galal, A.; Pullarkat, V.; Stock, W.; Cassaday, R. D.; Shah, B. D.; Faramand, R.; Muffly, L.; ROCCA Consortium; Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Impact of Prior Inotuzumab Ozogamicin Treatment on Brexucabtagene Autoleucel outcomes in Adults with B-cell ALL. Aldoss, I.; Roloff, G. W.; Faramand, R. G.; Kopmar, N. E.; Lin, C.; Advani, A. S.; Dekker, S. E.; Gupta, V. K.; O'Connor, T. E.; Jeyakumar, N.; Muhsen, I. N.; Valtis, Y. K.; Zhang, A.; Miller, K.; Sutherland, K. C.; Dykes, K. C.; Ahmed, M.; Chen, E. C.; Zambrano, H.; Bradshaw, D.; Mercadal, S.; Schwartz, M. S.; Tracy, S. I.; Dholaria, B.; Kubiak, M. J.; Mukherjee, A.; Majhail, N. S.; Battiwalla, M.; Mountjoy, L.; Malik, S. A.; Mathews, J.; Shaughnessy, P. J.; Logan, A.; Ladha, A.; Stefan, M.; Guzowski, C.; Hoeg, R. T.; Hilal, T.; Moore, J.; Connor, M.; O'Dwyer, K. M.; Hill, L. C.; Tsai, S. B.; Sasine, J. P.; Solh, M. M.; Lee, C. J.; Kota, V.; Koura, D.; Veeraputhiran, M.; Blunk, B.; Oliai, C.; Leonard, J. T.; Frey, N. V.; Park, J. H.; Luskin, M. R.; Bachanova, V.; Galal, A.; Bishop, M. R.; Stock, W.; Cassaday, R. D.; Pullarkat, V. A.; Shah, B. D.; Muffly, L.; Blood advances
  • Air pollutant impact on disease characteristics and outcomes in patients with acute myeloid leukemia. Palmer, A.; Rauscher, G.; Abraham, I.; Burkart, M.; Dave, A.; Raptis, N.; Aleem, A.; Gannamani, V.; Erra, A.; Monick, S.; Galvez, C.; Shah, S.; Rahmani Youshanlouei, H.; Larson, M. L.; Zia, M.; Tsai, S. B.; Altman, J. K.; Stock, W.; Khan, I.; Patel, A. A.; Blood advances
  • Busulfan, melphalan and carfilzomib high-dose chemotherapy and autologous haematopoietic stem cell transplantation in multiple myeloma. Hagen, P.; Norton, J.; Tsai, S.; Campo, L.; Lee, M.; Gomez, K.; Stiff, P.; British journal of haematology
  • Structural racism is a mediator of disparities in acute myeloid leukemia outcomes. Abraham, I. E.; Rauscher, G. H.; Patel, A. A.; Pearse, W. B.; Rajakumar, P.; Burkart, M.; Aleem, A.; Dave, A.; Bharadwaj, S.; Paydary, K.; Acevedo-Mendez, M.; Goparaju, K.; Gomez, R.; Carlson, K.; Tsai, S. B.; Quigley, J. G.; Galvin, J. P.; Zia, M.; Larson, M. L.; Berg, S.; Stock, W.; Altman, J. K.; Khan, I.; Blood
  • Low mean post-transplantation tacrolimus levels in weeks 2-3 correlate with acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation from related and unrelated donors. Hagen, P. A.; Adams, W.; Smith, S.; Tsai, S.; Stiff, P.; Bone marrow transplantation
  • Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults. Tsai, S. B.; Rhodes, J.; Liu, H.; Shore, T.; Bishop, M.; Cushing, M. M.; Gergis, U.; Godley, L.; Kline, J.; Larson, R. A.; Mayer, S.; Odenike, O.; Stock, W.; Wickrema, A.; van Besien, K.; Artz, A. S.; Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning. Tsai, S. B.; Liu, H.; Shore, T.; Fan, Y.; Bishop, M.; Cushing, M. M.; Gergis, U.; Godley, L.; Kline, J.; Larson, R. A.; Martinez, G.; Mayer, S.; Odenike, O.; Stock, W.; Wickrema, A.; van Besien, K.; Artz, A. S.; Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation